Pharmacological evaluation of "glyoherb": A polyherbal formulation on streptozotocin-induced diabetic rats

International Journal of Diabetes in Developing Countries

Volumn 30, Issue 1, 2010, Pages 1-7

  Thakkar, Nima V ^a   Patel, Jagruti A ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Diabetes mellitus; Glyoherb; Hyperlipidemia; Streptozotocin

Indexed keywords

EID: 77949582294     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.60001     Document Type: Article

References (34)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025. Diabetes Care 1998;21:1414-1431
2. Kameswara Rao B, Giri R, Kesavalu MM, Rao A. Herbal medicine in the management of diabetes mellitus. Manphar Vaidhya Patrika 1997;1:33-35
3. Cryer PE. Hypoglycemic agents. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. Vol 2. McGraw-Hill; 2001. p. 2138-2143
4. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and endocrine pancreas. In: Gilman AG, Goodman LS, Rall TW, Murad F, editors. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1679-1714
5. Winocour PH, Ishola M, Durrington PN. Validation of the friedewald's formula for the measurement of low density lipoprotein cholesterol in insulin dependant diabetes mellitus. Clin Chim Acta 1989;179:79-83.
6. Trinder P. Determination of blood glucose using an oxidase peroxidase system with a non carcinogen chromogen. J Clin Pathol 1969;22:158.
7. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-1080
8. Fossati P. Enzymatic determination of serum triglycerides. Principle Clin Chem 1982;28:2077.
9. Gidez WM, Webb M. Revision of cholesterol determination. J Biochem 1950;187:97-106.
10. Palton CJ, Crouch SR. spectrophotometric and kinetics investigation of the berthelot reaction for the determination of ammonia. Anal Chem 1977;49:464-469
11. Bartels A, Boehmer M. Microdetermination of creatinine. Clin Chim Acta 1971;32:81-85
12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358
13. Beutler E, Kelley BM. The effect of sodium nirate on RBC glutathione. Experientia 1963;19:96-97
14. Mishra SS, Sharma AL, Sharma S. Phytochemical and pharmacological studies on Launaea nudicaulis. Indian J Pharmacol 1979;11:63.
15. Aeibi H. In: Bergmeyer HV, editor. Catalase: Methods of enzymatic analysis. Chemie, Weinheim, Germany: 1974. p. 673-684
16. Rodrigues B, McNeill JH. Cardiac function in spontaneously hypertensive diabetic rats. Am J Physiol 1986;251:H571-80.
17. Hofteizer B, Carpenter and AM: Comparison of STZ induced diabetes in rats, including volumetric quantization of pancreatic islet cells. Diabetologia 1973;9:178-184
18. Murali B, Goyal RK. effect of chronic treatment with losartan on streptozotocin induced diabetic rats. Indian J Exp Biol 2002;40:31-34
19. Babu V, Gangadevi T, Subramoniam A. Antidiabetic activity of ethanol extract of Cassia Kleinii leaf in streptozotocin induced diabetic rats and isolation of an active fraction and toxicity evaluation of the extract. Indian J Pharmacol 2003;35:290-296
20. Tahiliani AG, Vadlamudi RV, Mcneill JH. Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment. Can J Physiol Pharmacol 1983,61:516-523
21. Marles RJ, Farnsworth NR. Antidiabetic plants and their constituents. Phytomedicine 1995;2:137-189
22. Sy GY, Cisse A, Nongonierma RB, Sarr M, Mbodj NA, Faye B. Hypoglycemic and antidiabetic activity of acetonic extract of Veronia colorata leaves in normoglycemic and alloxan induced diabetic rats. J Ethnopharmacol 2005;98:171-175
23. Roy S, Sehgal R, Padhy BM, Kumar VL. Antioxidant and protective effect of latex of Calotropis procera against alloxan induce diabetes in rats. J Ethnopharmacol 2005;102:470-473
24. Alford FP, Martin FIR, Pearson MJ. Significance and interpretation of mildly abnormal oral glucose tolerance test. Diabetalogia 1971;7:173-180
25. Gold AH. The effect of diabetes and insulin on liver glycogen synthetase activation. J Biol Chem 1970;245:903-905
26. Balasse EO, Bier DM Havel RJ. Early effects of anti-insulin serum on hepatic metabolism of plasma free fatt y acids in dogs. Diabetes 1972;21:280-284
27. Nikkila EA, Huttunen JK, Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Diabetes 1977;26:11-21.
28. Bagdade, JD, Porte DJ, Bierman EL. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes 1968;17:127-130
29. Ceriello A, Quatraro A, Giugliano D. New insights on non enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992; 9:297-299
30. Wolff SP, Dean RT. Glucose auto-oxidation and protein modification: The potential role of "autoxidative glycosylation" in diabetes. Biochem J 1987;245:243-250
31. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993;42:801-813
32. Ceriello A. Oxidative stress and glycemic regulation. Metab 2000;49:27-29
33. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26 :1277-1294
34. Nag B, Medicherla S, Sharma SD. Orally active fraction of momordica charantia, active peptides thereof and their use in the treatment of diabetes. US Patent 6,391,854:1-14, 2002.